Related Experiment Video
Updated: Feb 25, 2026
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
1.5K
The relationship between pulmonary hypertension and obstructive sleep apnea
Hang S Wong1, Adrian J Williams, YingJuan Mok
1aSleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK bChangi General Hospital, Simei, Singapore cKing's College London, London, UK.
Current Opinion in Pulmonary Medicine
|August 9, 2017
Summary
Obstructive sleep apnea (OSA) can cause pulmonary hypertension, affecting 17-53% of patients. Continuous positive airway pressure is an effective treatment for this condition.
Area of Science:
- Cardiology
- Pulmonology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is frequently linked to pulmonary hypertension.
- This association often leads to a poorer prognosis if left untreated.
- However, OSA-associated pulmonary hypertension is underrecognized by clinicians.
Purpose of the Study:
- To review the prevalence of pulmonary hypertension in OSA patients.
- To explore the pathophysiology, clinical presentation, and treatment options.
- To discuss the prognosis of this condition.
Main Methods:
- This is a review article.
- Information was gathered from existing literature on OSA and pulmonary hypertension.
Main Results:
- Pulmonary hypertension prevalence in OSA ranges from 17% to 53%.
- The pathophysiology is complex and not fully understood.
- Continuous positive airway pressure (CPAP) is effective in treating OSA-associated pulmonary hypertension.
Conclusions:
- OSA-associated pulmonary hypertension is a significant clinical issue.
- Further research is needed for a better understanding of this disease entity.
Related Concept Videos
01:21Sleep Apnea
622
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
622
01:30Pulmonary Hypertension: Classification and Pathogenesis
703
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
703
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
676
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
676
01:17Other Pulmonary Disorders
1.7K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
653
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
653
01:29Pulmonary Embolism I: Introduction
942
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
942